These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10450981)

  • 1. Novel benzopyrano[3,4-c]pyrrole derivatives as potent and selective dopamine D3 receptor antagonist.
    Dubuffet T; Newman-Tancredi A; Cussac D; Audinot V; Loutz A; Millan MJ; Lavielle G
    Bioorg Med Chem Lett; 1999 Jul; 9(14):2059-64. PubMed ID: 10450981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dopamine D3 receptor partial agonist, BP 897, is an antagonist at human dopamine D3 receptors and at rat somatodendritic dopamine D3 receptors.
    Wicke K; Garcia-Ladona J
    Eur J Pharmacol; 2001 Jul; 424(2):85-90. PubMed ID: 11476753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [3H]S33084: a novel, selective and potent radioligand at cloned, human dopamine D3 receptors.
    Cussac D; Newman-Tancredi A; Sezgin L; Millan MJ
    Naunyn Schmiedebergs Arch Pharmacol; 2000 May; 361(5):569-72. PubMed ID: 10832613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derivatives of (R)-2-amino-5-methoxytetralin: antagonists and inverse agonists at the dopamine D2A receptor.
    Höök BB; Brege C; Linnanen T; Mikaels A; Malmberg A; Johansson AM
    Bioorg Med Chem Lett; 1999 Aug; 9(15):2167-72. PubMed ID: 10465538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agonist and inverse agonist activity at the dopamine D3 receptor measured by guanosine 5'--gamma-thio-triphosphate--35S- binding.
    Malmberg ; Mikaels ; Mohell N
    J Pharmacol Exp Ther; 1998 Apr; 285(1):119-26. PubMed ID: 9536001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G protein activation by human dopamine D3 receptors in high-expressing Chinese hamster ovary cells: A guanosine-5'-O-(3-[35S]thio)- triphosphate binding and antibody study.
    Newman-Tancredi A; Cussac D; Audinot V; Pasteau V; Gavaudan S; Millan MJ
    Mol Pharmacol; 1999 Mar; 55(3):564-74. PubMed ID: 10051542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel (R)-2-amino-5-fluorotetralins: dopaminergic antagonists and inverse agonists.
    Malmberg A; Höök BB; Johansson AM; Hacksell U
    J Med Chem; 1996 Oct; 39(22):4421-9. PubMed ID: 8893836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutive coupling of a chimeric dopamine D2/alpha 1B receptor to the phospholipase C pathway: inverse agonism to silent antagonism by neuroleptic drugs.
    Wurch T; Boutet-Robinet EA; Palmier C; Colpaert FC; Pauwels PJ
    J Pharmacol Exp Ther; 2003 Jan; 304(1):380-90. PubMed ID: 12490615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S33084, a novel, potent, selective, and competitive antagonist at dopamine D(3)-receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626.
    Millan MJ; Gobert A; Newman-Tancredi A; Lejeune F; Cussac D; Rivet JM; Audinot V; Dubuffet T; Lavielle G
    J Pharmacol Exp Ther; 2000 Jun; 293(3):1048-62. PubMed ID: 10869410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6-(4-Benzylpiperazin-1-yl)benzodioxanes as selective ligands at cloned primate dopamine D(4) receptors.
    Hodgetts KJ; Kieltyka A; Brodbeck R; Tran JN; Wasley JW; Thurkauf A
    Bioorg Med Chem; 2001 Dec; 9(12):3207-13. PubMed ID: 11711296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-time analysis of dopamine: antagonist interactions at recombinant human D2long receptor upon modulation of its activation state.
    Pauwels PJ; Tardif S; Wurch T; Colpaert FC
    Br J Pharmacol; 2001 Sep; 134(1):88-97. PubMed ID: 11522600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NGB 2904 and NGB 2849: two highly selective dopamine D3 receptor antagonists.
    Yuan J; Chen X; Brodbeck R; Primus R; Braun J; Wasley JW; Thurkauf A
    Bioorg Med Chem Lett; 1998 Oct; 8(19):2715-8. PubMed ID: 9873609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological and immunochemical evidence of the dopamine D3 receptor in the goat carotid body.
    Wang ZY; Herman JK; O'Halloran KD; Keith IM; Bisgard GE
    Adv Exp Med Biol; 2001; 499():49-53. PubMed ID: 11729932
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanisms of inverse agonism of antipsychotic drugs at the D(2) dopamine receptor: use of a mutant D(2) dopamine receptor that adopts the activated conformation.
    Wilson J; Lin H; Fu D; Javitch JA; Strange PG
    J Neurochem; 2001 Apr; 77(2):493-504. PubMed ID: 11299312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: I. Receptor-binding profile and functional actions at G-protein-coupled receptors.
    Millan MJ; Mannoury la Cour C; Novi F; Maggio R; Audinot V; Newman-Tancredi A; Cussac D; Pasteau V; Boutin JA; Dubuffet T; Lavielle G
    J Pharmacol Exp Ther; 2008 Feb; 324(2):587-99. PubMed ID: 18024789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that dopamine D3 receptors participate in clozapine-induced hypothermia.
    Millan MJ; Audinot V; Melon C; Newman-Tancredi A
    Eur J Pharmacol; 1995 Jul; 280(2):225-9. PubMed ID: 7589191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonergic agonists behave as partial agonists at the dopamine D2 receptor.
    Rinken A; Ferré S; Terasmaa A; Owman C; Fuxe K
    Neuroreport; 1999 Feb; 10(3):493-5. PubMed ID: 10208577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the human dopamine D3 receptor expressed in transfected cell lines.
    MacKenzie RG; VanLeeuwen D; Pugsley TA; Shih YH; Demattos S; Tang L; Todd RD; O'Malley KL
    Eur J Pharmacol; 1994 Jan; 266(1):79-85. PubMed ID: 7907989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194.
    Audinot V; Newman-Tancredi A; Gobert A; Rivet JM; Brocco M; Lejeune F; Gluck L; Desposte I; Bervoets K; Dekeyne A; Millan MJ
    J Pharmacol Exp Ther; 1998 Oct; 287(1):187-97. PubMed ID: 9765337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
    Cosi C; Carilla-Durand E; Assié MB; Ormiere AM; Maraval M; Leduc N; Newman-Tancredi A
    Eur J Pharmacol; 2006 Mar; 535(1-3):135-44. PubMed ID: 16554049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.